Target intelligence / Profile preview

H-2 class I histocompatibility antigen, K-B alpha chain presenting SIINFEKL peptide (H-2Kb-SIINFEKL)

Target
H-2Kb-SIINFEKL
Molecular classification
Major Histocompatibility Complex (MHC) class I, Antigen-presenting complex, Receptor
01

Overview

The MHC class I peptide-binding groove presenting the SIINFEKL peptide is a cornerstone model in immunology, representing the H-2Kb molecule (UniProt: P01899) complexed with the immunodominant octapeptide from chicken ovalbumin (OVA). This complex is essential for studying the mechanisms of antigen processing and presentation to CD8+ T cells, particularly using the OT-I transgenic mouse model (PubMed: 7504010). Biologically, the complex is formed within the endoplasmic reticulum and transported to the cell surface, where it acts as a specific ligand for the T-cell receptor (TCR). In research and drug development, it is used as a target for TCR-like antibodies, such as the 25-D1.16 clone (PubMed: 8246777), and to evaluate the potency of vaccines and T-cell-based therapies. While the SIINFEKL peptide itself is not a human pathogen-derived antigen, the system serves as a high-affinity proxy for understanding how the immune system identifies and eliminates cells presenting non-self or mutated self-peptides. Consequently, it is a vital tool in the development of immunotherapies for cancer and infectious diseases.

Other names
MHC-I/SIINFEKL complexH-2Kb/SIINFEKLOvalbumin peptide-MHC complexpMHC complexSIINFEKL-H-2Kb
02

Mechanism of action

The complex acts as a ligand for the T-cell receptor (TCR) on CD8+ cytotoxic T lymphocytes, triggering signal transduction and immune effector functions.

03

Biological functions

Antigen presentationImmune responseT-cell activationCD8+ T-cell recognition
04

Disease associations

CancerInfectionAutoimmunity
05

Safety considerations

Cross-reactivity with self-peptidesCytokine release syndrome in therapeutic modelsImmunological tolerance
06

Interacting drugs

OT-I T-cell receptor

2 more in the full profile.

07

Biomarkers

H-2Kb-SIINFEKL tetramer25-D1.16 monoclonal antibody binding

Beyond the preview

Go deeper on H-2 class I histocompatibility antigen, K-B alpha chain presenting SIINFEKL peptide (H-2Kb-SIINFEKL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on H-2 class I histocompatibility antigen, K-B alpha chain presenting SIINFEKL peptide (H-2Kb-SIINFEKL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call